Conversion Point: Valid Form Fill Age Range: 30-80 Gender: All GEO: US Only Traffic Allowed: Email, Social, Banner, Native, Push, SEO, Search, Brand Bidding No Incent No Co-Reg No Survey No SMS No Adult Send ad creatives and LP to AM for approval Forbidden traffic types/false Advertisements Will NOT Be Paid For Fake/false celebrity ads/endorsements are strictly prohibited Ages: 18+ Gender: Any Compensation: Participants who qualify for the study will receive trial-related procedures and study medication at no cost and may be compensated up to $1300 for their time, in addition to travel support for transportation expenses, lodging, and reimbursement for meals. Study Details: The purpose of this clinical study is to see how effective an investigational oral medication is at helping to treat Thyroid Eye Disease (TED) associated with Graves’ Disease or Hashimoto Thyroiditis. Travel support will be provided for participants who live outside of the study site area. You may be asked to attend 1 screening visit to determine if you are eligible to enroll in the study. If enrolled, you will receive either the medication being tested in this study or a placebo to be taken twice a day for 6 months. After the treatment period, you will continue to be monitored by the study physician for a period of up to two years. Depending on your response to the study drug, you may be given the option to enroll in a follow-up study. There will be 15 study visits where you will complete various procedures and laboratory tests. Participants who qualify for the study will receive trial-related procedures and study medication at no cost and may be compensated up to $1300 for their time, in addition to travel support for transportation expenses, lodging, and reimbursement for meals. The doctor conducting the study will be able to provide you with more information about the study requirements. Qualifications: -Must be diagnosed with either Graves' Disease or Hashimotos Thyroiditis -Experiencing symptoms only for up to a year - not longer - Cannot be diabetic

SmartAdv